HomeInsightsBoard of Directors

Astrazeneca Pharma India Ltd Board of Directors

Astrazeneca Pharma India Ltd Board of Directors

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

0.7 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 09, 2024

Board of Directors at Astrazeneca Pharma India Ltd

Name
Designation
Bhavana AgrawalExecutive Director
Hooi ChuahNon Executive Director
Narayan SeshadriChairman & Independent Directo
Revathy AshokNon-Exec. & Independent Dir.
Sanjeev PanchalManaging Director

Key Highlights

  • Narayan K Seshadri continues to serve as the Chairman & Independent Directo in 2024, maintaining the same position as in the previous year.
  • Revathy Ashok continues to serve as the Non-Exec. & Independent Dir. in 2024, maintaining the same position as in the previous year.
  • Shilpa Divekar Nirula joins the board as Non-Exec. & Independent Dir., in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Sanjeev Panchal joins the board as Managing Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Hooi Bien Chuah joins the board as Non Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

PRICE

-

stock direction

Last updated on:

Last Ten Days Market Price

Date
leftPrice (₹)right
08 Nov 20247317.65
07 Nov 20247517
06 Nov 20247608.65
05 Nov 20247478
04 Nov 20247379.4
01 Nov 20247550.3
31 Oct 20247606.7
30 Oct 20247349.05
29 Oct 20247386.55
28 Oct 20247055.65

Company Fundamentals for Astrazeneca Pharma India Ltd

Market Cap

18,294 Cr

EPS

52.4

P/E Ratio (TTM) *

139.6

P/B Ratio (TTM) *

25.7

Day’s High *

7543.05

Day’s Low

7284.6

DTE *

0.0

ROE *

22.7

52 Week High

8139.85

52 Week Low

4050.15

ROCE *

30.8

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Astrazeneca Pharma India Ltd News Hub

News

Astrazeneca Pharma India to announce Quarterly Result

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...

Read more

25 Oct 202416:11

News

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed b...

Read more

24 Sep 202408:54

News

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and Nation...

Read more

24 Sep 202412:00

News

Volumes spurt at Astrazeneca Pharma India Ltd counter

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Schneider Electric Infrastructure Lt...

Read more

24 Sep 202414:30

News

AstraZeneca slumps on recording dismal Q1 performance

Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter...

Read more

08 Aug 202416:08

News

Astrazeneca Pharma India to hold board meeting

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 8...

Read more

24 Jul 202416:06

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Board of Directors of Astrazeneca Pharma India Ltd

How are members of Astrazeneca Pharma India Ltd Board of Directors selected?

Members of the Astrazeneca Pharma India Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Astrazeneca Pharma India Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Astrazeneca Pharma India Ltd Board of Directors?

Shareholders can interact with the Astrazeneca Pharma India Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Astrazeneca Pharma India Ltd Board of Directors meet?

The Astrazeneca Pharma India Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Astrazeneca Pharma India Ltd Board of Directors?

The Astrazeneca Pharma India Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Astrazeneca Pharma India Ltd?

The current Board of Directors at Astrazeneca Pharma India Ltd includes Narayan K Seshadri( Chairman & Independent Directo) ,Revathy Ashok( Non-Exec. & Independent Dir.) ,Shilpa Divekar Nirula( Non-Exec. & Independent Dir.) ,Sanjeev Panchal( Managing Director) ,Hooi Bien Chuah( Non Executive Director) . The full list can be found on Astrazeneca Pharma India Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*